U.S. FDA investigating AstraZeneca's COVID-19 vaccine candidate
Reuters had on Monday reported based on sources the U.S. trial was still on hold, pending FDA and safety panel investigations. Enrollment in the British drugmaker's global trials of the vaccine, which it is developing with researchers at Oxford University, was paused on Sept. 6, after a safety event

Full story is loading. Click here if it doesn't...